In vivo pharmacological profile of novel, potent, stable BK antagonists at B 1 and B2 receptors
- 30 June 1996
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 33 (1-3) , 191-193
- https://doi.org/10.1016/0162-3109(96)00037-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Involvement of B1 and B2 receptors in bradykinin‐induced rat paw oedemaBritish Journal of Pharmacology, 1995
- Induction of bradykinin B1 receptors in vivo in a model of ultra‐violet irradiation‐induced thermal hyperalgesia in the ratBritish Journal of Pharmacology, 1993
- Evidence for participation of B1 and B2 kinin receptors in formalin‐induced nociceptive response in the mouseBritish Journal of Pharmacology, 1993
- Mediation by B1 and B2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogsBritish Journal of Pharmacology, 1993
- Antinociceptive activity of the bradykinin B1 and B2 receptor antagonists, des-Arg9, [Leu8]-BK and HOE 140, in two models of persistent hyperalgesia in the ratPain, 1993
- A bradykinin (BK)1 receptor antagonist blocks capsaicin‐induced ear inflammation in miceBritish Journal of Pharmacology, 1990
- Modified formalin test: characteristic biphasic pain responsePain, 1989
- Hydrolysis of opioid hexapeptides by carboxypeptidase NBiochemical Pharmacology, 1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- A rapid method for the preparation of microvilli from rabbit kidneyBiochemical Journal, 1974